… by producing airway smooth-muscle relaxation, although β 2 -agonists and anticholinergics
achieve this effect through different mechanisms. Anticholinergic bronchodilators (in …

… in FEV 1 following use of an inhaled bronchodilator. In a … Smoking cessation resulted in
an appreciable improvement … anticholinergic bronchodilator on the rate of decline of FEV 1 : …

… clinical trial of smoking cessation and inhaled bronchodilator (ipratropium) therapy in … study
because smoking cessation has a powerful effect on mortality in heavy smokers with airway …

… In conclusion, smoking cessation increased bronchodilator response, and response did not
… of smoking cessation and bronchodilator (ipratropium) therapy in volunteer smokers aged 35…

… Inhaled anticholinergic antimuscarinic drugs approved for the treatment of … Effects of smoking
intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline …

… of Health, is a 5-year clinical trial to determine the effect of special intervention with an intensive
smoking cessation … ipratropium bromide, an anticholinergic bronchodilator, or placebo by …

… intervention program combining intensive smoking cessation counseling and an inhaled
anticholinergic bronchodilator … underwent pre- and post-bronchodilator spirometry annually [7, 8]…

… of anticholinergic bronchodilator therapy are available at minimal risk of side effects since …
severe and disabling despite smoking cessation and optimal bronchodilator therapy. A steroid …

… the number of canisters filled for bronchodilators, including albuterol and ipratropium bromide,
and/or the having filled a prescription for a nebulized bronchodilator), the Seattle Index of …

… Besides, smoking cessation is essential in preventing development of cardiovascular …
in one session - by combining a beta-2 agonist and anticholinergic bronchodilator - and …